Table 1.
Step 1: Define patients with diabetes mellitus in VISN 10a | |
From October 1, 2001 to present, the patient had any combination of ICD-9-CM diagnosis codes (250.xx, 357.2, 362.0, 366.41) on at least three separate dates of clinical encounters | |
or | |
From October 1, 2001 to present, the patient had a diabetes-specific medicationb dispensed from a VISN 10 pharmacy on at least two separate dates | |
Step 2: Define active patients versus not active patients with diabetes | |
Active patients | Not active patients |
Date of death = null and at least one of two conditions met: | If conditions for active are not met, then patient is not active |
1. The patient had a primary care clinic visit within the past 18 months | |
or | |
2. The patient had a diabetes-specific medicationb dispensed from a VISN 10 pharmacy within the past 18 months | |
Step 3: Define the clinic group most responsible for diabetes care for each active patient | |
Active patients | |
Find the most recent primary care clinic visit within the past 18 months. Based on the location of the visit, assign the patient to: | |
Site (a mutually exclusive list of five VHA sites in Ohio) | |
Chillicothe | |
Cincinnati | |
Cleveland | |
Dayton | |
Columbus | |
Clinic group (a subset of clinics within each site) | |
If the patient has no primary care clinic visits within the past 18 months, then classify as unassigned |
VISN 10 is the VA Integrated Service Network 10.
Diabetes-specific medications are any sulfonylurea, biguanide, thiazolidenedione, metiglinide, α-glucosidase inhibitor, insulin, or glucose meter test strips.